Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

CUSIP: 05280R100

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Total 13F shares
50,829,136
Total 13F value
$143,849,865
Holder snapshot 6 signals
Share change
-2,116,396
SEC-reported price per share
$2.83
Number of holders
57
Value change
-$7,115,566
Number of buys
24
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
266,837,198

Security key

05280R100

Report period

Q2 2022

Institutions

57

Top holders

10

AUTL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2022 Previous quarter: Q1 2022 Autolus Therapeutics plc SEC filings Autolus Therapeutics plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Blackstone Inc.
Disclosed value leader
Blackstone Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 6.7% Showing 1-6 of 15 holder rows.

Quick read

Blackstone Inc. leads the comparable SEC ownership view at 6.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Blackstone Inc.'s linked filing trail.
Comparable ownership Top 5
Blackstone Inc. 6.7%
Syncona Portfolio Ltd 2.8%
Nantahala Capital Management, LLC 1.6%
Frazier Life Sciences Management,... 1.4%
CITADEL ADVISORS LLC 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Blackstone Inc.
13F
Company
13F
6.7%
$75,000,000
17,985,611 shares
 — 31 Mar 2022
Syncona Portfolio Ltd
13F
Company
13F
2.8%
$38,130,000
7,346,829 shares
 — 31 Mar 2022
Nantahala Capital Management, LLC
13F
Company
13F
1.6%
$18,124,000
4,346,327 shares
 — 31 Mar 2022
Frazier Life Sciences Management, L.P.
13F
Company
13F
1.4%
$15,624,000
3,746,857 shares
 — 31 Mar 2022
CITADEL ADVISORS LLC
13F
Company
13F
1.3%
$14,647,000
3,512,513 shares
 — 31 Mar 2022
Tetragon Partners GP Ltd
13F
Company
13F
1.1%
$11,784,000
2,825,937 shares
 — 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
57
Shares
50,829,136
Rows available
57
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
60
Q2 2022 holders
57
Holder diff
-3
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .